Citigroup »

Onkure Therapeutics Inc-a shares owned by Citigroup

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Citigroup

Quarter filed Position value Share count Share price at filing
2025-03-31 $836 190 4.40
2024-12-31 $876 102 8.60

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Indl (XLI)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)

View all positions for Citigroup

Top funds holding Onkure Therapeutics Inc-a

Acorn Capital Advisors
Citadel Advisors
Shay Capital
Vanguard Group
Highbridge Capital Management
Vestal Point Capital
BlackRock
StepStone
Cantor Fitzgerald, L. P.
NEA Management Company
Carlyle
Prosight Management
Renaissance Technologies
Rangeley Capital
Tang Capital Management

View all funds holding Onkure Therapeutics Inc-a